Menu Search

Two IPOs from the HBM Healthcare Investments portfolio increase net asset value

Two members of the HBM Healthcare Investments portfolio of private companies went public: Swiss ObsEva, and California-based Anaptys Biosciences.

The two IPOs combined raised the net asset value per HBM-share by CHF 2.30 (+1.6%).

Read more in the link opposite